Koers Creative Medical Technology Holdings, Inc. Other OTC
Aandelen
CELZ
US22529Y2000
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | 563K 523K | Marktkapitalisatie | 5,96 mln. 5,54 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -6 mln. -5,58 mln. | Nettowinst (verlies) 2025 * | -6 mln. -5,58 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 10,6 x |
K/w-verhouding 2024 * |
-0,94
x | K/w-verhouding 2025 * |
-1,17
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 93,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 63 | 18-05-16 | |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 01-02-16 |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Susan Snow
BRD | Director/Board Member | 67 | 02-12-21 |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 01-02-16 |
Chief Executive Officer | 63 | 18-05-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+38,61% | 12,63 mld. | |
+313,59% | 8,49 mld. |